Changeflow GovPing Healthcare & Life Sciences EP4144736A1 - Azabenzimidazoles AMPA Receptor M...
Routine Notice Added Final

EP4144736A1 - Azabenzimidazoles AMPA Receptor Modulators, Janssen, Apr 15, 2026

Favicon for changeflow.com EPO Patent Bulletin - Organic Chemistry (C07D)
Published
Detected
Email

Summary

The EPO published patent application EP4144736A1 titled 'Azabenzimidazoles and Their Use as AMPA Receptor Modulators' on April 15, 2026, covering novel heterocyclic compounds as AMPA receptor modulators for neurological and pain conditions. The application was filed by Janssen Pharmaceutica NV with 13 named inventors. The patent designates 37 EPO contracting states.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Organic Chemistry (C07D) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 22 changes logged to date.

What changed

The EPO published patent application EP4144736A1 for azabenzimidazole derivatives as AMPA receptor modulators. The application discloses heterocyclic compounds classified under C07D 471/04 and C07D 471/14 with therapeutic applications in neurological disorders (A61P 25/00) and pain management (A61P 29/00). The application designates 37 EPO contracting states including all major European jurisdictions. Third parties have a nine-month window from the publication date to file observations or oppose the application.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

AZABENZIMIDAZOLES AND THEIR USE AS AMPA RECEPTOR MODULATORS

Publication EP4144736A1 Kind: A1 Apr 15, 2026

Applicants

JANSSEN Pharmaceutica NV

Inventors

BERRY, Cynthia G.B, CHEN, Gang, JOURDAN, Fabrice Loic, LEBOLD, Terry Patrick, LIN, David Wei, PENA PIÑÓN, Miguel Angel, RAVULA, Suchitra, SAVALL, Bradley M., SWANSON, Devin M., WU, Dongpei, ZHANG, Wei, AMERIKS, Michael K.

IPC Classifications

C07D 471/04 20060101AFI20260306BHEP A61K 31/437 20060101ALI20260306BHEP C07D 471/14 20060101ALI20260306BHEP A61P 25/00 20060101ALN20260306BHEP A61P 29/00 20060101ALN20260306BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Notice
Branch
International
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4144736A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Pharmaceutical compounds Patent filings
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Medical Devices

Get alerts for this source

We'll email you when EPO Patent Bulletin - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!